Patents
Patents for C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845)
09/2001
09/11/2001US6288050 Steroid sulfatase inhibitors and methods for making and using the same
09/05/2001CN1311684A Propylactic treatments of neovascularisation in macular degeneration
09/05/2001CN1070499C Process for prepn. of 6 alpha, 9 alpha-difluorinated steroids and intermediates thereof
09/04/2001US6284887 Process for preparing carboxamido-4-azasteroids
08/2001
08/30/2001WO2001062771A1 Steroid derivatives with an additional ring annulated to ring a and use of these derivatives for the preparation of meiosis regulating medicaments
08/29/2001EP1127890A1 Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
08/09/2001WO2001056578A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
08/09/2001WO2001056577A1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
08/09/2001CA2397790A1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
08/09/2001CA2396197A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
08/08/2001EP0889051B1 Triterpene derivatives and remedies for liver diseases
08/02/2001WO2001055122A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
08/02/2001WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
07/2001
07/26/2001WO2001053321A2 Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers
07/26/2001WO2001052856A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action
07/12/2001WO2001049703A2 Substituted sapogenins and their use
07/10/2001US6258946 Chemical intermediate for diuretic
07/05/2001WO2001047945A1 Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
07/05/2001US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture
07/04/2001CN1302208A Smilagenin and anzurogenin-D for curing Alzheimer's disease
07/04/2001CN1067976C Asiatic acid derivatives its manufacturing method and dermatological agent containing it
06/2001
06/27/2001CN1301166A Steroidal saponins for treating alzheimer's disease
06/26/2001US6251883 Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
06/20/2001CN1299821A Lactone compound and its synthesis and use
06/14/2001WO2001042272A2 Eplerenone crystalline form exhibiting enhanced dissolution rate
06/14/2001WO2001041535A2 Eplerenone crystalline form
06/14/2001CA2362845A1 Eplerenone crystalline form
06/14/2001CA2362669A1 Eplerenone crystalline form exhibiting enhanced dissolution rate
06/13/2001CN1298877A Tacca chantrieri andre ketonic internal ester and its use
06/07/2001WO2001040256A1 Taccalonolides and their use
06/07/2001WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases
06/07/2001CA2391096A1 3-methylene steroid derivatives
06/06/2001EP1104302A1 Prophylactic treatments of neovascularisation in macular degeneration
06/05/2001US6242619 19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function
06/05/2001CA2065861C Process for the manufacture of budesonide
05/2001
05/17/2001WO2001034132A2 Use of an aldosterone antagonist for treating restenosis
05/17/2001CA2390561A1 Use of an aldosterone antagonist for treating restenosis
05/16/2001EP0876394B1 Preparation of (11beta,16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno 17,16-d]oxazole-3,20-dione
05/08/2001US6228851 Adsorption on styrenic or acrylic polymer matrix; desorption, elution
05/02/2001CN1293572A Method and means for treating glomerulonephritis
05/02/2001CN1293200A Process for preparing saponin library by one-step or two-step random reaction
05/02/2001CN1293199A Saponin library of rhammose-substituted beta-o-gluco-diosgenin and its preparing process and application
04/2001
04/26/2001WO2001029036A2 Allosteric sites on muscarinic receptors
04/26/2001CA2386149A1 Allosteric sites on muscarinic receptors
04/05/2001WO2001023408A1 5-hydroxysapogenin derivatives with anti-dementia activity
04/05/2001WO2001023407A1 Sapogenin derivatives and their use in the treatment of cognitive dysfunction
04/05/2001WO2001023406A1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
04/05/2001CA2640998A1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
04/04/2001EP1087987A1 A compound, wf002, production thereof and use thereof
04/03/2001US6211168 Methods for preparation and use of 1α,24 (S)-dihydroxy vitamin D2
03/2001
03/27/2001USRE37116 Nitrosated and nitrosylated compounds, and compositions and their use for treating respiratory disorders
03/27/2001US6207403 Kinesin motor modulators derived from the marine sponge Adocia
03/21/2001EP0738275B9 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
03/15/2001WO2001018027A1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
03/13/2001US6201018 Triterpene derivatives and remedies for liver diseases
03/07/2001EP1081157A1 Processes for the preparation of steroid derivatives, intermediates therefor and processes for the preparation of the intermediates
03/07/2001CN1062869C Prednisolone derivs
03/06/2001US6197762 Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders
02/2001
02/28/2001CN1285750A New composition of matter
02/27/2001US6194565 Antiinflammatory agent
02/27/2001CA2081205C Steroids which inhibit angiogenesis
02/22/2001WO2000064882A3 Enantiomers of mercapto lactones and processes for their synthesis
02/14/2001EP0643071B1 Compound for inhibiting bone resorption and accelerating osteogenesis
02/14/2001CN1061988C Method of extracting dioscorea saponin from dioscorea plant
01/2001
01/30/2001US6180803 Steroid drugs
01/30/2001US6180780 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
01/23/2001US6177418 Epoxidized and/or hydroxylated prostane derivatives derived from a fusidium coccineum fungus metabolite isolated from metabolite mixture of fusidic acid
01/17/2001EP1067939A1 Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
01/10/2001EP1066042A2 Steroidal saponins for treating alzheimer's disease
01/10/2001EP1066033A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
01/10/2001EP0885240B1 Process for the purification of 11beta-21-dihydroxy-2'-methyl-5'betah-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
01/02/2001US6169178 Process for the preparation of 16,17 acetals of pregnane derivatives with control of the epimeric distribution at the C-22 position
12/2000
12/28/2000WO2000054780A3 Corticosteroid formulation
12/26/2000US6166000 For treating breast cancer
12/13/2000EP0749438B1 Novel silyl compounds and their use
12/06/2000EP1057809A1 Carbonate derivatives of retinol, process for their preparation and utilisations
12/06/2000EP1056461A1 Method and means for treating glomerulonephritis
11/2000
11/30/2000WO2000071563A2 Taccalonolide microtubule stabilizing agents
11/30/2000WO2000043408A3 Steroid sulfatase inhibitors and methods for making and using the same
11/29/2000EP0900233B1 Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
11/23/2000WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
11/22/2000CN1058724C Use of steroid compound for preparing medicaments
11/21/2000US6150336 Steroidal glycosides
11/16/2000WO2000067801A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/16/2000CA2368831A1 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/14/2000US6147065 14-α, 17-α-C2 bridged norprogesterone derivatives
11/09/2000WO2000066612A1 Androgen glycosides and androgenic activity thereof
11/08/2000EP1049475A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA)
11/08/2000EP0738275B1 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
11/07/2000US6143910 Methods for preparation and use of 1α, 24(S) -dihydroxy vitamin D2
11/02/2000WO2000064882A2 Enantiomers of mercapto lactones and processes for their synthesis
10/2000
10/31/2000US6140316 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
10/31/2000US6140308 Colon or ileum-specific glucocorticosteroid derivatives
10/25/2000CN1057770C Application of 19,11 beta-bridged sterodal compound in pharmaceutical working
10/25/2000CN1057767C Androstanes with inducing hypothalamic effects
10/18/2000CN1270174A Total triterpenoid saponin in coral ardisa root or other plants in same family and preparing process thereof
10/12/2000WO2000059922A1 14,15-.alpha.-methylene equilenine derivatives, methods for producing the same and medicaments containing them
10/11/2000CN1057303C Preparation process for 16 beta-methyl steroid and new intermediates thereof
10/05/2000DE19915576A1 New equilenine derivatives, useful as antioxidative estrogenic hormonal steroids for e.g. prophylactic geriatrics in women and men
09/2000
09/28/2000WO2000056759A1 Processes for the preparation of steroid derivatives, intermediates therefor and processes for the preparation of the intermediates
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 39